Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Malignant Melanoma

Free Subscription Articles published in Am J Dermatopathol Retrieve available abstracts of 86 articles: HTML format

Single Articles

April 2024
1. SRIVATSA S, Smith CJ, Sangueza OP, Miedema J, et al
   Lymphangitic Melanomatosis: Case Report of Intralymphatic Spread of Melanoma in a 66-year-old Man.
   Am J Dermatopathol. 2024 Apr 4. doi: 10.1097/DAD.0000000000002696.
   PubMed     Abstract available
   
   
   March 2024
2. LOPER R, Schon MP, Mitteldorf C
   Melanocyte Density in the Diagnosis of Melanoma In Situ in Sun-Damaged Skin.
   Am J Dermatopathol. 2024 Mar 19. doi: 10.1097/DAD.0000000000002680.
   PubMed     Abstract available
   
   
   
3. CASILLAS AC, Muhlbauer A, Barragan VA, Jefferson I, et al
   A Comparison of Preferentially Expressed Antigen in Melanoma Immunohistochemistry and Diagnostic Gene Expression-Profiling Assay in Challenging Melanocytic Proliferations.
   Am J Dermatopathol. 2024;46:137-146.
   PubMed     Abstract available
   
   
   
4. LOHMAN ME, Kim YH, Steen AJ, Demer AM, et al
   The Promise and Pitfalls of PRAME Immunohistochemistry During Mohs Surgery: Early Findings.
   Am J Dermatopathol. 2024;46:191-192.
   PubMed    
   
   
   January 2024
5. WILLS A, Dibbern M, Frierson HF, Raghavan SS, et al
   Metastatic Undifferentiated Melanoma Mimicking a Primary Bone Tumor: A Potential Diagnostic Pitfall.
   Am J Dermatopathol. 2024 Jan 3. doi: 10.1097/DAD.0000000000002622.
   PubMed     Abstract available
   
   
   December 2023
6. MCTIGHE SP, Taylor EA, Allbritton J, Lewin-Smith MR, et al
   Localized Cutaneous Argyria at the Site of a Prior Melanoma Excision Confirmed by Scanning Electron Microscopy With Energy Dispersive X-ray Analysis.
   Am J Dermatopathol. 2023 Dec 26. doi: 10.1097/DAD.0000000000002610.
   PubMed     Abstract available
   
   
   November 2023
7. NEIMY H, Helmy JE, Snyder A, Valdebran M, et al
   Artificial Intelligence in Melanoma Dermatopathology: A Review of Literature.
   Am J Dermatopathol. 2023 Nov 14. doi: 10.1097/DAD.0000000000002593.
   PubMed     Abstract available
   
   
   
8. KENNY MG, Nguyen M, Modi M, Eilers D, et al
   Melanoma Mimicker: Pigmented Mammary Paget Disease in a Man.
   Am J Dermatopathol. 2023 Nov 14. doi: 10.1097/DAD.0000000000002588.
   PubMed     Abstract available
   
   
   
9. TURNER N, Ko CJ, McNiff JM, Galan A, et al
   Pitfalls of PRAME Immunohistochemistry in a Large Series of Melanocytic and Nonmelanocytic Lesions With Literature Review.
   Am J Dermatopathol. 2023 Nov 14. doi: 10.1097/DAD.0000000000002584.
   PubMed     Abstract available
   
   
   
10. DONATI M, Grossmann P, Mansour B, Kazakov DV, et al
    Melanocytic Neoplasm With KIT and APC Mutations: A New Subtype of Melanocytoma?
    Am J Dermatopathol. 2023 Nov 14. doi: 10.1097/DAD.0000000000002556.
    PubMed     Abstract available
    
    
    
11. KIM JC, Choi JW, Kim YC
    Comparison of Melanocyte-Associated Immunohistochemical Markers in Acral Lentiginous Melanoma and Acral Benign Nevi.
    Am J Dermatopathol. 2023;45:748-752.
    PubMed     Abstract available
    
    
    
12. LEZCANO C, Jungbluth AA, Busam KJ
    Immunohistochemistry for PRAME in Dermatopathology.
    Am J Dermatopathol. 2023;45:733-747.
    PubMed     Abstract available
    
    
    August 2023
13. VANDERBECK K, Rothrock AT, Cho WC, Nagarajan P, et al
    PRAME and LEF1 in Combined Deep Penetrating Nevus and Combined Blue Nevus: Utility and Pitfalls.
    Am J Dermatopathol. 2023;45:549-556.
    PubMed     Abstract available
    
    
    
14. WEN D, Chen T, Martin RCW
    A Rare Case of a Basomelanocytic Tumor.
    Am J Dermatopathol. 2023;45:e64-e67.
    PubMed     Abstract available
    
    
    July 2023
15. OCANHA XAVIER JP, Xavier JCC Jr, da Silva MG, Marques MEA, et al
    Vitamin D Receptor and Retinoid X Receptor Alpha in Melanocytic Benign Lesions and Melanoma.
    Am J Dermatopathol. 2023 Jul 28. doi: 10.1097/DAD.0000000000002507.
    PubMed     Abstract available
    
    
    
16. SHERIDAN C, O'Connor MC, Sitton B, Bass J, et al
    Nevus Spilus With Dermatoheliosis: A Histologic Mimicker of Melanoma in Situ at Melanoma Excision Margins.
    Am J Dermatopathol. 2023 Jul 11. doi: 10.1097/DAD.0000000000002493.
    PubMed     Abstract available
    
    
    
17. BOUTKO A, Hagstrom M, Lampley N, Roth A, et al
    PRAME Immunohistochemical Expression and TERT Promoter Mutational Analysis as Ancillary Diagnostic Tools for Differentiating Proliferative Nodules From Melanoma Arising in Congenital Nevi.
    Am J Dermatopathol. 2023;45:437-447.
    PubMed     Abstract available
    
    
    May 2023
18. O'NEILL P, Amanuel B, Mesbah Ardakani N
    Cutaneous Malignant Melanoma With Rhabdomyosarcomatous Dedifferentiation: an Immunohistological and Molecular Case Study With Literature Review.
    Am J Dermatopathol. 2023 May 2. doi: 10.1097/DAD.0000000000002451.
    PubMed     Abstract available
    
    
    
19. MCFADDEN JR, Syku M, Barney RE, Stevanovic M, et al
    A Novel Method to Detect Copy Number Variation in Melanoma: Droplet Digital PCR for Quantitation of the CDKN2A Gene, a Proof-of-Concept Study.
    Am J Dermatopathol. 2023 May 2. doi: 10.1097/DAD.0000000000002436.
    PubMed     Abstract available
    
    
    April 2023
20. PISANI D, Micallef D, Scerri J, Betts A, et al
    Neuroendocrine Transdifferentiation in Cutaneous Melanoma: A Case Report and Review of the Literature.
    Am J Dermatopathol. 2023;45:264-268.
    PubMed     Abstract available
    
    
    
21. CORTEZ DE ALMEIDA RF, Sponchiado Assoni A, Cabrera Pereira JP, Erthal de Britto Pereira Kassuga Roisman L, et al
    Pigmented Bowen Disease in the Acral Region: A Diagnostic Challenge.
    Am J Dermatopathol. 2023;45:235-236.
    PubMed    
    
    
    March 2023
22. MCFADDEN JR, Chaudhari AS, Stevanovic M, Tsongalis GJ, et al
    Gain of CCND1 May Occur Too Infrequently in Cutaneous Melanoma, and Too Late in Melanomagenesis, to Be Diagnostically Useful: Genomic Analysis of 88 Cases.
    Am J Dermatopathol. 2023 Mar 20. doi: 10.1097/DAD.0000000000002420.
    PubMed     Abstract available
    
    
    February 2023
23. BOUTKO A, Asadbeigi S, Roth A, Lampley N, et al
    TERT Promoter Mutational Analysis as an Ancillary Diagnostic Tool for Diagnostically Challenging Melanocytic Neoplasms.
    Am J Dermatopathol. 2023 Feb 17. doi: 10.1097/DAD.0000000000002366.
    PubMed     Abstract available
    
    
    
24. HARTZELL C, Hernandez E, Arriola AGP
    A Rare Collison of Vulvar Melanoma and Extramammary Paget Disease: Case Report and Review of the Literature.
    Am J Dermatopathol. 2023;45:133-136.
    PubMed    
    
    
    
25. DONATI M, Steiner P, Kazakov DV
    BAP1-Inactivated Melanoma Arising From BAP1-Inactivated Melanocytic Tumor in a Patient With BAP1 Germline Mutation: A Case Report and Review of the Literature.
    Am J Dermatopathol. 2023;45:117-122.
    PubMed     Abstract available
    
    
    
26. MATA DA, Lian CG, Hafeez F
    Determining the Association Between Melanomas and Fields of Melanocytic Dysplasia.
    Am J Dermatopathol. 2023;45:90-92.
    PubMed     Abstract available
    
    
    
27. DE WET J, Plessis PJD, Schneider JW
    Staged Excision of Lentigo Maligna of the Head and Neck: Assessing Surgical Excision Margins With Melan A, SOX10, and PRAME Immunohistochemistry.
    Am J Dermatopathol. 2023;45:107-112.
    PubMed     Abstract available
    
    
    January 2023
28. ELKEEB DM, Hopkins ZH, Bolender CM, Moreno C, et al
    A Single-Institution Cohort Study With Nevi of Special Site: Recurrence, Progression to Melanoma, and Patterns of Management.
    Am J Dermatopathol. 2023;45:28-39.
    PubMed     Abstract available
    
    
    December 2022
29. MASSONE C, Chiodi S, Zanette M, Sola S, et al
    Cutaneous Squamomelanocytic Tumor: An Additional Case Report With Dermoscopic Features.
    Am J Dermatopathol. 2022 Dec 19. doi: 10.1097/DAD.0000000000002367.
    PubMed    
    
    
    
30. KIMBALL KM, Craig E, Barrick C, Usmani A, et al
    Malignant Melanoma Arising in a Prolific Nevus Sebaceus With Colonization of Trichoblastoma.
    Am J Dermatopathol. 2022 Dec 7. doi: 10.1097/DAD.0000000000002355.
    PubMed     Abstract available
    
    
    
31. ALMANZA J, Dobry A, Ejadi S, Jakowatz J, et al
    Histopathologic Evolution of Melanocytes Associated With Rapid Clinical Progression of Melanoma: Clinicopathologic Presentation of Hyperprogressive Disease in a Patient Treated With Immunotherapy.
    Am J Dermatopathol. 2022;44:921-924.
    PubMed     Abstract available
    
    
    
32. RANSON M, Lai J, Van Brenk B, McCalmont TH, et al
    Plexiform Melanocytic Schwannoma: Report of a Second Case and Overview of a Rare Entity.
    Am J Dermatopathol. 2022;44:943-947.
    PubMed     Abstract available
    
    
    November 2022
33. MASSONE C, Stanganelli I, Ingordo V, Ferrara G, et al
    Clinicopathologic and Dermoscopic Features of 20 Cases of Spark's Nevus, a Dermoscopic Simulator of Melanoma.
    Am J Dermatopathol. 2022 Nov 7. doi: 10.1097/DAD.0000000000002323.
    PubMed     Abstract available
    
    
    September 2022
34. TABABA E, Teulings HE, Bhawan J
    Histopathologic Versus Clinical Margins in Melanoma.
    Am J Dermatopathol. 2022;44:703-704.
    PubMed    
    
    
    
35. LUPPI JB, Pereira de Souza R, Florezi GP, Nico MMS, et al
    The Role of Reflectance Confocal Microscopy in the Evaluation of Pigmented Oral Lesions and Their Relationship With Histopathological Aspects.
    Am J Dermatopathol. 2022;44:658-663.
    PubMed     Abstract available
    
    
    
36. ZIPPERER K, Good AJ, Gibson BR, Goodwin B, et al
    Cutaneous Malignant Squamomelanocytic Tumor: A Case Report of a Rare Neoplasm.
    Am J Dermatopathol. 2022 Sep 1. pii: 00000372-990000000-00080.
    PubMed     Abstract available
    
    
    July 2022
37. SANTANDREA G, Longo C, Borsari S, Lai M, et al
    Pigmented Actinic Keratosis Versus In Situ Melanoma: PRAME May Be Helpful.
    Am J Dermatopathol. 2022 Jul 29. pii: 00000372-990000000-00074.
    PubMed    
    
    
    
38. SNYDER AN, Zhang D, Dressen SL, Baltimore CA, et al
    Histologic Screening of Malignant Melanoma, Spitz, Dermal and Junctional Melanocytic Nevi Using a Deep Learning Model.
    Am J Dermatopathol. 2022 Jul 19. pii: 00000372-990000000-00064.
    PubMed     Abstract available
    
    
    
39. TAS F, Erturk K
    Major Histotypes in Skin Melanoma: Nodular and Acral Lentiginous Melanomas Are Poor Prognostic Factors for Relapse and Survival.
    Am J Dermatopathol. 2022 Jul 19. pii: 00000372-990000000-00063.
    PubMed     Abstract available
    
    
    
40. SHWE S, Yamamoto M, Linden KG, Lee BA, et al
    Tumoral Melanosis and Separate Granulomatous Inflammation due to Talimogene Laherparepvec.
    Am J Dermatopathol. 2022;44:541-543.
    PubMed    
    
    
    May 2022
41. BUR D, Thibodeaux Q, Keeling B
    Verrucous Melanoma Presenting as a Cutaneous Horn.
    Am J Dermatopathol. 2022 May 30. pii: 00000372-990000000-00040.
    PubMed     Abstract available
    
    
    
42. HSIEH R, Nico MMS, Camillo CMC, Oliveira KK, et al
    Actionable Mutation Profile of Sun-Protected Melanomas in South America.
    Am J Dermatopathol. 2022 May 3. pii: 00000372-990000000-00038.
    PubMed     Abstract available
    
    
    April 2022
43. GERAMI P, Benton S, Zhao J, Zhang B, et al
    PRAME Expression Correlates With Genomic Aberration and Malignant Diagnosis of Spitzoid Melanocytic Neoplasms.
    Am J Dermatopathol. 2022 Apr 27. pii: 00000372-990000000-00024.
    PubMed     Abstract available
    
    
    
44. IRELAND A, Williams B, Rijhumal A, Mesbah Ardakani N, et al
    Metastatic Melanoma to a Neurofibroma.
    Am J Dermatopathol. 2022 Apr 11. pii: 00000372-990000000-00020.
    PubMed     Abstract available
    
    
    
45. HUANG YY, Hrycaj SM, Chan MP, Stagner AM, et al
    PRAME Expression in Junctional Melanocytic Proliferations of the Conjunctiva: A Potential Biomarker for Primary Acquired Melanosis/Conjunctival Melanocytic Intraepithelial Lesions.
    Am J Dermatopathol. 2022 Apr 11. pii: 00000372-990000000-00017.
    PubMed     Abstract available
    
    
    
46. ADAMS SH, Huston TL, Lozeau D
    Intranodal Neurofibroma: A Case Report and Literature Review.
    Am J Dermatopathol. 2022;44:306-311.
    PubMed     Abstract available
    
    
    March 2022
47. BOOTHBY-SHOEMAKER W, Kwa M, Kohen L, Shaw B, et al
    A Rare Case of Primary Cutaneous Signet-Ring Cell Melanoma With Discrepant Findings on Gene Expression Profiling and Chromosomal Microarray Analysis.
    Am J Dermatopathol. 2022 Mar 22. pii: 00000372-990000000-00008.
    PubMed     Abstract available
    
    
    
48. SALARI B, Foreman RK, Emerick KS, Lawrence DP, et al
    Sinonasal Mucosal Melanoma: An Update and Review of the Literature.
    Am J Dermatopathol. 2022 Mar 22. pii: 00000372-990000000-00006.
    PubMed     Abstract available
    
    
    
49. WILLEMSEN M, Tio D, Krebbers G, Kasiem FR, et al
    Presence of Skin Tissue-Resident Memory T Cells in Human Nonmalignant and Premalignant Melanocytic Skin Lesions and in Melanoma.
    Am J Dermatopathol. 2022 Mar 21. pii: 00000372-990000000-00001.
    PubMed     Abstract available
    
    
    February 2022
50. PERRIN C
    Preferentially Expressed Nuclear Antigen in Melanoma Expression in Melanocytic Activation (Melanotic Macule) of the Nail Unit. A Potential Diagnostic Pitfall? A Study of 3 Cases.
    Am J Dermatopathol. 2022 Feb 25. pii: 00000372-900000000-97597.
    PubMed     Abstract available
    
    
    
51. TACHIBANA K, Goto K, Kukita Y, Honma K, et al
    BRAF Immunoexpression Can Be Intralesionally Heterogeneous but BRAF V600E Mutation Status Is Intralesionally Homogeneous and Interlesionally Concordant in Melanoma: A Study of 140 Lesions From 98 Patients.
    Am J Dermatopathol. 2022 Feb 2. pii: 00000372-900000000-97613.
    PubMed     Abstract available
    
    
    
52. KRAJISNIK A, Gharavi NM, Faries MB, Balzer BL, et al
    Immunohistochemistry for Preferentially Expressed Antigen in Melanoma in the Differential Diagnosis of Melanocytic Lesions of the Nail Apparatus.
    Am J Dermatopathol. 2022 Feb 2. pii: 00000372-900000000-97611.
    PubMed     Abstract available
    
    
    January 2022
53. MAHALINGAM M
    Pure and Mixed Desmoplastic Melanoma Subtypes Exhibit Distinct Genetic Drivers.
    Am J Dermatopathol. 2022 Jan 7. pii: 00000372-900000000-97622.
    PubMed    
    
    
    
54. KLINE N, Menge TD, Hrycaj SM, Andea AA, et al
    PRAME Expression in Challenging Dermal Melanocytic Neoplasms and Soft Tissue Tumors With Melanocytic Differentiation.
    Am J Dermatopathol. 2022 Jan 5. pii: 00000372-900000000-97630.
    PubMed     Abstract available
    
    
    November 2021
55. VALIGA AA, Fuller CG, Doyle JA, Lee JB, et al
    Sarcomatoid Dedifferentiated Melanoma: The Diagnostic Role of Next-Generation Sequencing.
    Am J Dermatopathol. 2021 Nov 2. pii: 00000372-900000000-97652.
    PubMed     Abstract available
    
    
    
56. WEISS A, Christensen RE, Maghari A, Wassef C, et al
    Primary Dermal Melanoma: A Case Report.
    Am J Dermatopathol. 2021 Nov 2. pii: 00000372-900000000-97650.
    PubMed     Abstract available
    
    
    October 2021
57. BRESSLER MY, Felice S, Yousefi N, Marghoob N, et al
    Combining Reflective Confocal Microscopy and Dynamic Optical Coherence Tomography to Diagnose Melanoacanthoma: Case Report.
    Am J Dermatopathol. 2021;43:736-739.
    PubMed     Abstract available
    
    
    September 2021
58. ZABALLOS P, Lara-Valencia P, Van Den Bossche K, Sanchez-Martinez E, et al
    Clear Cell Proliferations of the Skin: A Histopathologic Review.
    Am J Dermatopathol. 2021;43:607-636.
    PubMed     Abstract available
    
    
    July 2021
59. SIREF A, Kitahara S, Balzer B
    Proliferative Clonal T-Cell Infiltrate Mimicking a Cutaneous T-Cell Lymphoma Arising in Active Regression of Melanoma.
    Am J Dermatopathol. 2021 Jul 20. pii: 00000372-900000000-97697.
    PubMed     Abstract available
    
    
    
60. STRAKER RJ 3RD, Taylor LA, Neuwirth MG, Sinnamon AJ, et al
    Optimizing Detection of Lymphatic Invasion in Primary Cutaneous Melanoma With the Use of D2-40 and a Paired Melanocytic Marker.
    Am J Dermatopathol. 2021 Jul 7. pii: 00000372-900000000-97711.
    PubMed     Abstract available
    
    
    May 2021
61. FREDERICO IKS, Mesbah Ardakani N, Ryan AL, Cowley MJ, et al
    Spitz Melanoma of Childhood With A Novel Promoter Hijacking Anaplastic Lymphoma Kinase (C2orf42-ALK) Rearrangement.
    Am J Dermatopathol. 2021 May 17. pii: 00000372-900000000-97738.
    PubMed     Abstract available
    
    
    
62. GOOGE PB, Flanigan KL, Miedema JR
    Preferentially Expressed Antigen in Melanoma Immunostaining in a Series of Melanocytic Neoplasms.
    Am J Dermatopathol. 2021 May 11. pii: 00000372-900000000-97744.
    PubMed     Abstract available
    
    
    April 2021
63. HARVEY NT, Peverall J, Acott N, Mesbah Ardakani N, et al
    Correlation of FISH and PRAME Immunohistochemistry in Ambiguous Superficial Cutaneous Melanocytic Proliferations.
    Am J Dermatopathol. 2021 Apr 21. pii: 00000372-900000000-97762.
    PubMed     Abstract available
    
    
    
64. KRISHNAMURTHY K, Urioste SN, Cusnir M, Schwartz M, et al
    Analysis of Genetic Alterations in Cutaneous Malignant Melanomas Unveils Unique Loco-Regional Variations and Novel Predictors of Metastatic Potential.
    Am J Dermatopathol. 2021 Apr 13. pii: 00000372-900000000-97770.
    PubMed     Abstract available
    
    
    
65. KIM D, Compres EV, Zhang B, Khan AU, et al
    A Series of RET Fusion Spitz Neoplasms With Plaque-Like Silhouette and Dyscohesive Nesting of Epithelioid Melanocytes.
    Am J Dermatopathol. 2021;43:243-251.
    PubMed     Abstract available
    
    
    
66. SIAROV J, Neittaanmaki N, Molne J, Gillstedt M, et al
    Digital Quantification of Melanocytic Density in Resection Margins of Lentigo Maligna Using SOX10 Versus Hematoxylin-Eosin Staining.
    Am J Dermatopathol. 2021;43:273-277.
    PubMed     Abstract available
    
    
    March 2021
67. CHEN TC, Hitchcock MG
    Rate of Immunohistochemistry Utilization in the Diagnosis of Cutaneous Melanocytic Lesions.
    Am J Dermatopathol. 2021 Mar 30. pii: 00000372-900000000-97773.
    PubMed     Abstract available
    
    
    
68. PORCAR SAURA S, Guillen Climent S, Pinazo Canales MI, Monteagudo C, et al
    Melanocytic Hyperactivation Simulating an Acral Lentiginous Melanoma in a Patient With Parkinson Disease Treated by Levodopa.
    Am J Dermatopathol. 2021;43:238-241.
    PubMed    
    
    
    February 2021
69. DE VINCENTIIS L, Mariani MP, Ferrara G
    Dermatologic Oncology and Histopathology at a Secondary Care Centre During the Coronavirus Disease 2019 Pandemic.
    Am J Dermatopathol. 2021;43:160-162.
    PubMed    
    
    
    
70. BORRETTA LJ, Kirchhof MG, Crawford RI
    The Clinical Implication of Incidental Epidermodysplasia Verruciformis.
    Am J Dermatopathol. 2021;43:156-158.
    PubMed    
    
    
    January 2021
71. CHU S, Schrom KP, Tripathi R, Conic RRZ, et al
    Pure and Mixed Desmoplastic Melanomas: A Retrospective Clinicopathologic Comparison of 33 Cases.
    Am J Dermatopathol. 2021 Jan 26. pii: 00000372-900000000-97809.
    PubMed     Abstract available
    
    
    
72. SALGUERO I, Roustan G, Requena L, Suarez D, et al
    Immunophenotypic Differences in Tumor-Infiltrating Lymphocytes and Neovascularization Between Primary Cutaneous Melanoma With and Without Metastasis: An Immunohistochemical Study of 80 Cases.
    Am J Dermatopathol. 2021 Jan 26. pii: 00000372-900000000-97807.
    PubMed     Abstract available
    
    
    
73. TABABA E, Teulings HE, Bhawan J
    Differences Between Recommended Surgical Margins and Measured Histological Margins in Malignant Melanoma In Situ and Malignant Melanomas.
    Am J Dermatopathol. 2021 Jan 26. pii: 00000372-900000000-97805.
    PubMed     Abstract available
    
    
    
74. HENNING A, Billings S, Ko J, Weaver J, et al
    Atypical Cellular Blue Nevus With Necrosis Mimicking Melanoma Ex-Blue Nevus.
    Am J Dermatopathol. 2021 Jan 26. pii: 00000372-900000000-97803.
    PubMed     Abstract available
    
    
    
75. MODI MB, Moshiri AS, Klein WM, Karakousis G, et al
    Metastatic Melanoma With Features of Desmoplastic Melanoma in a Patient With Primary Cutaneous Superficial Spreading Melanoma With Epithelioid Features.
    Am J Dermatopathol. 2021 Jan 12. pii: 00000372-900000000-97823.
    PubMed     Abstract available
    
    
    
76. NASIR W, Howard T, Weiss E
    Melanoma Arising From a Pre-existing Neurofibroma in a Patient With No Prior Diagnosis of Systemic Neurofibromatosis 1 or 2: A Case Report.
    Am J Dermatopathol. 2021 Jan 12. pii: 00000372-900000000-97822.
    PubMed     Abstract available
    
    
    December 2020
77. SANTOS-BRIZ A, Canueto J, Carmen SD, Barrios B, et al
    Value of PD-L1, PD-1, and CTLA-4 Expression in the Clinical Practice as Predictors of Response to Nivolumab and Ipilimumab in Monotherapy in Patients With Advanced Stage Melanoma.
    Am J Dermatopathol. 2020;Publish Ahead of Print.
    PubMed     Abstract available
    
    
    
78. DONATI M, Nosek D, Waldenback P, Martinek P, et al
    MAP2K1-Mutated Melanocytic Neoplasms With a SPARK-Like Morphology.
    Am J Dermatopathol. 2020 Dec 1. doi: 10.1097/DAD.0000000000001840.
    PubMed     Abstract available
    
    
    November 2020
79. DONATI M, Nozicka J, Kastnerova L, Hajkova V, et al
    Primary Cutaneous Desmoplastic Melanoma With Collagen Rosettes and Pseudoglandular Features.
    Am J Dermatopathol. 2020 Nov 16. doi: 10.1097/DAD.0000000000001809.
    PubMed     Abstract available
    
    
    
80. TORRE-CASTRO J, Haya-Martinez L, Moya-Martinez C, Nunez-Hipolito L, et al
    Syringotropic Melanoma: A Diagnostic Challenge With Prognostic Implications.
    Am J Dermatopathol. 2020 Nov 16. doi: 10.1097/DAD.0000000000001853.
    PubMed     Abstract available
    
    
    
81. BOU-PRIETO A, Sarriera-Lazaro CJ, Valentin-Nogueras SM, Sanchez JE, et al
    Defining the Histopathological Term Atypical Intraepidermal Melanocytic Proliferation: A Retrospective Cross-Sectional Study.
    Am J Dermatopathol. 2020 Nov 16. doi: 10.1097/DAD.0000000000001851.
    PubMed     Abstract available
    
    
    August 2020
82. NGUYEN CV, Mueller JL, Lawson CN, Rubin AI, et al
    Lichenoid Nail Unit Changes in an Elderly Patient: Answer.
    Am J Dermatopathol. 2020;42:616-617.
    PubMed    
    
    
    July 2020
83. LOUW A, Creaney J, Thomas A, Van Vliet C, et al
    Histologically Diverse BAP1-Deficient Melanocytic Tumors in a Patient With BAP1 Tumor Predisposition Syndrome.
    Am J Dermatopathol. 2020 Jul 7. doi: 10.1097/DAD.0000000000001719.
    PubMed     Abstract available
    
    
    
84. RYAN MP, Bennett DD, Goodwin BP, Kelly BC, et al
    Basomelanocytic Neoplasms: A Report of Two Similar Tumors With Divergent Treatments.
    Am J Dermatopathol. 2020;42:530-532.
    PubMed     Abstract available
    
    
    February 2020
85. DONATI M, Kastnerova L, Martinek P, Grossmann P, et al
    Spitz Tumors With ROS1 Fusions: A Clinicopathological Study of 6 Cases, Including FISH for Chromosomal Copy Number Alterations and Mutation Analysis Using Next-Generation Sequencing.
    Am J Dermatopathol. 2020;42:92-102.
    PubMed     Abstract available
    
    
    January 2020
86. DONATI M, Kastnerova L, Cempirkova D, Vanecek T, et al
    Vulvar Pigmented Epithelioid Melanocytoma With a Novel HTT-PKN1 Fusion: A Case Report.
    Am J Dermatopathol. 2020 Jan 14. doi: 10.1097/DAD.0000000000001600.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Malignant Melanoma is free of charge.